Journal of Pediatrics Review

Published by: Kowsar

Hyperimmunoglobulin-D Syndrome in Children: A Review Article

Masoud Golpour 1 and Javad Ghaffari 2 , *
Authors Information
1 Associated Professor of Dermatology, Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
2 Professor of Allergy and Clinical Immunology, Infectious Disease Research Center with Focus on Nosocomial Infection, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Journal of Pediatrics Review: January 28, 2016, 4 (1); e4593
  • Published Online: January 26, 2016
  • Article Type: Review Article
  • Received: November 3, 2015
  • Accepted: January 21, 2016
  • DOI: 10.17795/jpr-4593

To Cite: Golpour M, Ghaffari J. Hyperimmunoglobulin-D Syndrome in Children: A Review Article, J Pediatr Rev. 2016 ;4(1):e4593. doi: 10.17795/jpr-4593.

Abstract
Copyright: Copyright © 0, Journal of Pediatrics Review. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
References
  • 1. van der Meer JW, Vossen JM, Radl J, van Nieuwkoop JA, Meyer CJ, Lobatto S, et al. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet. 1984; 1(8386): 1087-90[PubMed]
  • 2. Korppi M, Van Gijn ME, Antila K. Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report. Acta Paediatr. 2011; 100(1): 21-5[DOI][PubMed]
  • 3. Ombrello AK, Kastner DL. Herediatary periodic fever syndromes and other systemic autoinflammatory diseases. Nelson textbook of pediatrics, chapter 163, : 1193-12040
  • 4. Browne C, Timson DJ. In Silico Prediction of the Effects of Mutations in the Human Mevalonate Kinase Gene: Towards a Predictive Framework for Mevalonate Kinase Deficiency. Ann Hum Genet. 2015; 79(6): 451-9[DOI][PubMed]
  • 5. Haas D, Hoffmann GF. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis. 2006; 1: 13[DOI][PubMed]
  • 6. Topaloglu R, Ayaz NA, Waterham HR, Yuce A, Gumruk F, Sanal O. Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clin Rheumatol. 2008; 27(10): 1317-20[DOI][PubMed]
  • 7. Santos Rde L, Crovella S, Celsi F. Comment to Santos et al., "hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype". Gene. 2015; 559(1): 99-101[DOI][PubMed]
  • 8. Cuisset L, Drenth JP, Simon A, Vincent MF, van der Velde Visser S, van der Meer JW, et al. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet. 2001; 9(4): 260-6[DOI][PubMed]
  • 9. Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med. 2001; 345(24): 1748-57[DOI][PubMed]
  • 10. Hoffmann F, Lohse P, Stojanov S, Shin YS, Renner ED, Kery A, et al. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation. Eur J Hum Genet. 2005; 13(4): 510-2[DOI][PubMed]
  • 11. Stojanov S, Lohse P, Lohse P, Hoffmann F, Renner ED, Zellerer S, et al. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. Arthritis Rheum. 2004; 50(6): 1951-8[DOI][PubMed]
  • 12. Hoffman HM, Simon A. Recurrent febrile syndromes: what a rheumatologist needs to know. Nat Rev Rheumatol. 2009; 5(5): 249-56[DOI][PubMed]
  • 13. Hammoudeh M. Hyperimmunoglobulinemia D syndrome in an Arab child. Clin Rheumatol. 2005; 24(1): 92-4[DOI][PubMed]
  • 14. Simon A, Cuisset L, Vincent MF, van Der Velde-Visser SD, Delpech M, van Der Meer JW, et al. Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: its application as a diagnostic tool. Ann Intern Med. 2001; 135(5): 338-43[PubMed]
  • 15. Siewert R, Ferber J, Horstmann RD, Specker C, Heering PJ, Timmann C. Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease? Am J Kidney Dis. 2006; 48(3)-5[DOI][PubMed]
  • 16. Moussa T, Aladbe B, Taha RZ, Remmers EF, El-Shanti H, Fathalla BM. Overlap of familial Mediterranean fever and hyper-IgD syndrome in an Arabic kindred. J Clin Immunol. 2015; 35(3): 249-53[DOI][PubMed]
  • 17. Buhaescu I, Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications . Clin Biochem. 2007; 40: 575-84
  • 18. van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). 2008; 87(6): 301-10[DOI][PubMed]
  • 19. Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet. 1999; 22(2): 178-81[DOI][PubMed]
  • 20. Simon A, van der Meer JW, Vesely R, Myrdal U, Yoshimura K, Duys P, et al. Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Rheumatology (Oxford). 2006; 45(3): 269-73[DOI][PubMed]
  • 21. Grateau G, Duruoz MT. Autoinflammatory conditions: when to suspect? How to treat? Best Pract Res Clin Rheumatol. 2010; 24(3): 401-11[DOI][PubMed]
  • 22. Arkwright PD, McDermott MF, Houten SM, Frenkel J, Waterham HR, Aganna E, et al. Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept. Clin Exp Immunol. 2002; 130(3): 484-8[PubMed]
  • 23. Bodar EJ, Kuijk LM, Drenth JP, van der Meer JW, Simon A, Frenkel J. On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis. 2011; 70(12): 2155-8[DOI][PubMed]
  • 24. Ter Haar N, Lachmann H, Ozen S, Woo P, Uziel Y, Modesto C, et al. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis. 2013; 72(5): 678-85[DOI][PubMed]
  • 25. Kostjukovits S, Kalliokoski L, Antila K, Korppi M. Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience. Eur J Pediatr. 2015; 174(6): 707-14[DOI][PubMed]
  • 26. Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF, et al. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther. 2004; 75(5): 476-83[DOI][PubMed]
  • 27. Galeotti C, Meinzer U, Quartier P, Rossi-Semerano L, Bader-Meunier B, Pillet P, et al. Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency. Rheumatology (Oxford). 2012; 51(10): 1855-9[DOI][PubMed]
  • 28. Tsitsami E, Papadopoulou C, Speletas M. A case of hyperimmunoglobulinemia d syndrome successfully treated with canakinumab. Case Rep Rheumatol. 2013; 2013: 795027[DOI][PubMed]
  • 29. Stoffels M, Jongekrijg J, Remijn T, Kok N, van der Meer JW, Simon A. TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome. Rheumatology (Oxford). 2015; 54(2): 363-8[DOI][PubMed]
  • 30. Di Gangi M, Amato G, Converso G, Benenati A, Leonetti C, Borella E, et al. Long-term efficacy of adalimumab in hyperimmunoglobulin D and periodic fever syndrome. Isr Med Assoc J. 2014; 16(10): 605-7[PubMed]
  • 31. Chaudhury S, Hormaza L, Mohammad S, Lokar J, Ekong U, Alonso EM, et al. Liver transplantation followed by allogeneic hematopoietic stem cell transplantation for atypical mevalonic aciduria. Am J Transplant. 2012; 12(6): 1627-31[DOI][PubMed]
  • 32. Neven B, Valayannopoulos V, Quartier P, Blanche S, Prieur AM, Debre M, et al. Allogeneic bone marrow transplantation in mevalonic aciduria. N Engl J Med. 2007; 356(26): 2700-3[DOI][PubMed]
  • 33. Arkwright PD, Abinun M, Cant AJ. Mevalonic aciduria cured by bone marrow transplantation. N Engl J Med. 2007; 357(13): 1350[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .